Previous Page  5 / 15 Next Page
Information
Show Menu
Previous Page 5 / 15 Next Page
Page Background

Page 47

conferenceseries

.com

Volume 6, Issue 6 (Suppl)

OMICS J Radiol, an open access journal

ISSN: 2167-7964

Neuroradiology 2017

October 30 to November 01, 2017

October 30 to November 01, 2017 | San Antonio, USA

2

nd

International Conference on

Neuroscience, Neuroimaging & Interventional Radiology

Oxidative stress and neuroinflammation in schizophrenia detected by novel neuroimaging approaches

Fei Du

McLean Hospital-Harvard School of Medicine, USA

S

chizophrenia (SZ) is a common and severe psychiatric disorder characterized by abnormal cognition and perception. Despite

its public health impact and a century of biological research, the pathophysiology of SZ remains poorly understood. Recently

accumulated evidence suggests that an immuno-oxidative pathway including oxidative stress, NMDAR hypofunction and

neuroinflammation may contribute to disruptions in brain circuits in SZ. The redox pair of Nicotinamide adenine dinucleotide

(NAD+) and its reduced form NADH have long been implicated in biological activities such as cellular energy metabolism, calcium

homeostasis, gene expression and immunological functions. Despite the crucial roles of NAD+ and NADH in cellular metabolism

and physiology, its non-invasive in vivo detection is extremely challenging. Recently we demonstrate the feasibility of 31P MRS-based

NAD quantification at 4 T MRI-scanner and apply this novel method in patients with SZ. We found a substantial and significant

reduction in the redox ratio (i.e., NAD+/NADH) in the chronic and first-episode SZ patients. Intracellular redox ratio is influenced

by multiple cellular signaling events and may constitute a metabolic integrator for local metabolic status within cells. Therefore, our

work provides new insights into the pathophysiology of SZ, as well as a biomarker for tracking the impact of treatment interventions.

In addition, the identification of pharmacological compounds acting on brain redox status as an innovative therapeutic approach

for first-episode psychosis treatment and neuroimaging biomarker measurements such as glutathione (antioxidant) and glutamate/

glutamine (index of NMDAR hypofunction) will be discussed.

fdu@mclean.harvard.edu

OMICS J Radiol 2017, 6:6, (Suppl)

DOI: 10.4172/2167-7964-C1-019